"StudyMetrix Research is a privately-owned, independent research clinic qualified to conduct Phase II-IV clinical trials, in the Greater St. Charles, Missouri area. We are conveniently located approximately at the intersection of Cave Springs and Mexico Rd. Our facility provides easy access and plenty of free parking. ​ With more than 100 years of combine experience in clinical trials, we have provided a friendly, efficient, safe and professional environment for our study participants and accurate, quality data for our study sponsors. We have conducted over 600 clinical trials of investigational drugs and devices. We pride ourselves on our ability to provide rapid study startup, approval and rapid patient enrollment for our studies."

During the past decade, StudyMetrix Research conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 27 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 25 clinical trials were completed. i.e. 56.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "StudyMetrix Research" #1 sponsor was "Eli Lilly and Company" with 24 trials, followed by "Pfizer" with 7 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored, "Allergan" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "StudyMetrix Research" #1 collaborator was "Clinvest Research, LLC" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Avanir Pharmaceuticals" with 1 trials as a collaborator and "Clinvest" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "StudyMetrix Research" are "Migraine" (20 trials), "Obesity" (6 trials), "Diabetic Peripheral Neuropathic Pain" (4 trials), "Episodic Migraine" (4 trials) and "Overweight" (4 trials). Many other conditions were trialed in "StudyMetrix Research" in a lesser frequency.

Most popular intervention types in "StudyMetrix Research" are "Drug" (49 trials), "Device" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Tirzepatide" (6 trials), "Rimegepant" (4 trials), "Dulaglutide" (3 trials) and "LY3016859" (3 trials). Other intervention names were less common.

The vast majority of trials in "StudyMetrix Research" are 54 trials for "All" genders.

Currently, there are NaN active trials in "StudyMetrix Research". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in StudyMetrix Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in StudyMetrix Research, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 5 trials that are defined as “Not Applicable".